Literature DB >> 3033507

Do vasodilators prolong life in heart failure?

M Packer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3033507     DOI： 10.1056/NEJM198706043162308

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Duration and reproducibility of initial hemodynamic effects of flosequinan in patients with congestive heart failure.

Authors:  G L Bartels; W J Remme; A C Wiesfeld; F J Kok; M P Look; X H Krauss; H A Kruyssen
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  Effect of enalapril on mortality in congestive heart failure. Follow-up survival data from the CONSENSUS trial.

Authors:  K Swedberg; J Kjekshus
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 3.  The place of ACE inhibitors in the current treatment of chronic heart failure.

Authors:  J McMurray; A D Struthers
Journal:  Postgrad Med J       Date:  1988-09       Impact factor: 2.401

4.  Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.

Authors:  A J Cowley; R D Wynne; K Stainer; L Fullwood; J M Rowley; J R Hampton
Journal:  BMJ       Date:  1988-07-16

Review 5.  Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

6.  Therapeutic advances in heart failure.

Authors:  Thomas Meinertz; Helmut Drexler; Hanjörg Just
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.